Voya Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Voya Financial Advisors's XBI Position: Q2 2021 in Review
Voya Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 4,038 shares — an estimated $525K sold.
Voya Financial Advisors first reported a position in XBI in Q3 2016 and held it in 19 quarters. The position peaked at $1.16M in Q3 2018. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.
- Voya Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
- Voya Financial Advisors sold 4,038 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $525K.
- Voya Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 19 quarters.
- Voya Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.16M in Q3 2018.
- 663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.
Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.